Serological response to a third booster dose of BNT162b2 COVID-19 vaccine among seronegative cancer patients

Einat Shacham Shmueli*, Yaacov R. Lawrence, Galia Rahav, Amit Itay, Yaniv Lustig, Naama Halpern, Ben Boursi, Ofer Margalit

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Serological response to a third booster dose of BNT162b2 COVID-19 vaccine among seronegative cancer patients'. Together they form a unique fingerprint.

Keyphrases

Biochemistry, Genetics and Molecular Biology

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science